$VMD News

Viemed Healthcare: Maintaining 'Buy' Rating Post Q1 On Improving Capital Efficiency

Viemed Healthcare, Inc. 2026 Q1 - Results - Earnings Call Presentation

Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript

Viemed Healthcare Q1 2026 Earnings Call: Complete Transcript

Viemed Healthcare (NASDAQ:VMD) Q1 2026 Earnings: Revenue Beat Offset by EPS Miss and Margin Pressure

Viemed Healthcare Raises FY2026 Sales Guidance from $310.000M-$320.000M to $312.000M-$320.000M vs $315.450M Est

Viemed Healthcare Q1 EPS $0.06 Misses $0.09 Estimate, Sales $75.414M Beat $74.400M Estimate

Viemed Healthcare Inc (NASDAQ:VMD) Identified as a CAN SLIM Growth Candidate

VIEMED HEALTHCARE INC (NASDAQ:VMD) Passes High-Growth Momentum and Trend Template Screen

CAN SLIM Stock Screener Identifies Growth Leader Viemed Healthcare (NASDAQ:VMD)

Viemed Healthcare Q4 Earnings Call Highlights

Viemed (VMD) Q4 2025 Earnings Call Transcript

Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript

Viemed Healthcare, Inc. Q4 2025 Earnings Call Summary

Viemed Healthcare, Inc. 2025 Q4 - Results - Earnings Call Presentation

Viemed Healthcare Inc (NASDAQ:VMD) Stands Out as a CAN SLIM Growth Candidate

Viemed Healthcare shares are trading lower after the company reported mixed Q4 financial results and issued FY26 sales guidance below estimates.

Viemed Healthcare shares are trading lower after the company reported mixed Q4 financial results and issued FY26 sales guidance below estimates.

Viemed Healthcare Inc (NASDAQ:VMD) Shares Fall After Q4 Revenue Miss and Cautious 2026 Outlook

Viemed Healthcare Announces Record 2025 Financial Results